|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C12N 9/10 | (2006.01) |
| C12P 21/00 | (2006.01) |
| (11) | Patento numeris | 3942028 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20718990.3 |
| Europos patento paraiškos padavimo data | 2020-03-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-01-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/023415 |
| Data | 2020-03-18 |
| (87) | Numeris | WO 2020/191088 |
| Data | 2020-09-24 |
| (30) | Numeris | Data | Šalis |
| 201962819762 P | 2019-03-18 | US |
| (72) |
GEURTSEN, Jeroen , NL
BURGHOUT, Pieter, Jan , NL
WEERDENBURG, Eveline, Marleen , NL
POOLMAN, Jan, Theunis , NL
FAE, Kellen, Cristhina , NL
IBARRA YON, Patricia , NL
ABBANAT, Darren, Robert , NL
KEMMLER, Stefan, Jochen , CH
KOWARIK, Michael, Thomas , CH
MALLY, Manuela , CH
GAMBILLARA, FONCK, Veronica , CH
BRAUN, Martin, Edward , CH
CARRANZA SANDMEIER, Maria, Paula , CH
|
| (73) |
Janssen Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
GlaxoSmithKline Biologicals S.A. , Rue de l'Institut, 89, 1330 Rixensart, BE |
| (54) | METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF |
| METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF |